Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
4.010
+0.100 (2.56%)
At close: May 20, 2026, 4:00 PM EDT
3.990
-0.020 (-0.50%)
After-hours: May 20, 2026, 7:39 PM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $9.2 million as of May 20, 2026. Its market cap has increased by 368.05% in one year.
Market Cap
9.20M
Enterprise Value
2.05M
1-Year Change
368.05%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $9.20M, a decrease of -97.16%. That is a compound annual growth rate of -55.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 8.97M | 535.76% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
| Dec 10, 2021 | 323.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVie | 10.18M |
| CalciMedica | 10.15M |
| BioCardia | 10.00M |
| Quoin Pharmaceuticals | 8.91M |
| Bolt Biotherapeutics | 8.78M |
| Curanex Pharmaceuticals | 8.57M |
| NuCana | 8.49M |
| Imunon | 8.48M |